Nextgen Biomed Ltd  

(Public, TLV:NXGN)   Watch this stock  
Find more results for NXGN
-0.20 (-1.38%)
Mar 30 - Close
TLV data delayed by 20 mins - Disclaimer
Currency in ILA unless noted
Range 14.00 - 14.60
52 week 0.14 - 14.60
Open 14.50
Vol / Avg. 607,828.00/528,407.00
Mkt cap 11.63M*
P/E     -
Div/yield     -
EPS -0.06*
Shares 83.02M
Beta     -
Inst. own     -
Mar 30, 2015
Q4 2014 Nextgen Biomed Ltd Earnings Release (Estimated)

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -405.43% -1193.19%
Return on average equity - -
Employees 187 -
CDP Score - -


+972-3-6070320 (Phone)
+972-3-6070323 (Fax)

Website links


Nextgen Biomed Ltd., formerly Sela Group.Com Ltd., is an Israel-based company. Previously, the Company provided training and services to the Israeli and global high technology sector, software development, digital hardware design, information security, management of computing systems, information technology (IT), personnel positioning, consultancy, outsourcing, Website casting and Website conferencing in Israel and abroad. The Company's clients included the Israeli Defense Ministry, Raphael, Elisra, Avirnaoutic Industry, Amdocs, BMC, Comverse, Texas Instruments, The National Israeli Electricity Company, General Health Services Company, Bank Leumi, Pelephone, EDS, NDS, ECI Telecom and others. Currently, Nextgen Biomed Ltd. via its subsidiary, Sindolor Medical Ltd., operates research and development of injection devices while reducing pain.

Officers and directors

Uri Ackerman Chief Executive Officer
Noa Shelach Chief Executive Officer
Age: 43
Shlomo Zakai Member of the Management Board
Ron Bentsur Director
Age: 49
Itzhak Israel Director
Ofer Elsheich External Director
Age: 48
Sigal Grinboim External Director
Age: 49
Eli Arad Independent Director
Age: 40